By HEATHER MURPHY
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Published: April 15, 2019 at 08:00PM
from NYT Health https://nyti.ms/2GlsXBT
via IFTTT
from WordPress http://bit.ly/2V1YZMl
via IFTTT
No comments:
Post a Comment